SlideShare a Scribd company logo
Vascular Access for CRRT
Timothy E Bunchman
Professor & Director
Helen DeVos Children’s Hospital
Grand Rapids, MI
(Thanks to Rick Hackbarth MD for his help
and slides)
Access
 If you don’t have it you might as well go
home.
 This is the most important aspect of CRRT
therapy.
 Adequacy.
 Filter life.
 Increased blood loss.
 Staff satisfaction.
Vascular Access
 Ideal Catheter Characteristics
 Easy Insertion
 Permits Adequate Blood Flow without Vessel Damage
 Minimal Technical Flaws
 High Recirculation Rate
 Kinking
 Shorter and Larger Catheters
SIZE DOES MATTER
 Lower Resistance
 Improved Bloodflow
Vascular Access for CRRT
 Match catheter size to patient size and
anatomical site
 One dual- or triple-lumen or two single lumen
uncuffed catheters
 Sites
 femoral
 internal jugular
 avoid sub-clavian vein if possible
Pediatric CRRT Vascular Access:
Performance = Blood Flow
 Minimum 30 to 50 ml/min to minimize access
and filter clotting
 Maximum rate of 400 ml/min/1.73m2 or
 10-12 ml/kg/min in neonates and infants
 4-6 ml/kg/min in children
 2-4 ml/kg/min in adolescents
Vascular Access
Two questions to be answered-
 What size catheter to use?
 Where to put it?
Femoral vs IJ catheter performance
 26 femoral
 19 > 20 cm
 7 < 20cm
 13 IJ
 Qb 250 ml/min (ultrasound dilution)
 Recirculation measurement by ultrasound
dilution method
Little et al: AJKD 36:1135-9, 2000
Femoral vs IJ catheter performance
Type Number
Qb
(ml/min)
Recirculation(%) 95% CI
Femoral 26 237.1 13.1* 7.6 to 18.6
> 20cm 19 233.3 8.5** 2.9 to 13.7
< 20cm 7 247.5 26.3**
17.1 to
35.5
Jugular 13 226.4 0.4* -0.1 to 1.0
Little et al: AJKD 36:1135-9, 2000
* p<0.001
** p<0.007
Vascular Access
ppCRRT Registry Access Study
 13 Pediatric Institutions
 376 patients
 1574 circuits
 Circuit survival by Catheter size, site, and modality
Hackbarth R et al: IJAIO 30:1116-21, 2007
Vascular Access
Figure 2: Mean Patient Weight vs Catheter Size
0
20
40
60
80
100
5 French 7 French 8 French 9 French 10 French 11.5
French
12.5
French
Catheter Size
Kg
Hackbarth R et al: IJAIO 30:1116-21, 2007
Number of Patients
% Survival at 60
hours 
Catheter Size*
5 6 0 (p <0.0000)
7 57 43 (p < 0.002)
8 65 55 (NS)
9 35 51 (p < 0.002)
10 46 53 (NS)
11.5 71 57 (NS)
12.5 64 60 (NS)
Insertion Site
Internal Jugular 58 60 (p < 0.05)
Subclavian 31 51 (NS)
Femoral 260 52 (NS)
Hackbarth R et al: IJAIO 30:1116-21, 2007
Vascular Access
Hackbarth R et al: IJAIO 30:1116-21, 2007
Shorter life span
for 7 and 9 French
catheters (p< 0.002)
1st 72 hrs of circuit
life only
Figure 1: Catheter Location by Size
0
10
20
30
40
50
60
70
80
90
100
5 French 7 French 8 French 9 French 10 French 11.5 French 12.5 French
Catheter Size
%
Femoral
IJ
Subclavian
Unknown
Hackbarth R et al: IJAIO 30:1116-21, 2007
Vascular Access
“Location, location, location!”
Femoral Vein
Pros:
 Accessible under almost any conditions
 Easier to maintain hemostasis
Cons:
 Potential for kinking
 More recirculation
 Thrombosis
 Problematic flow with increased abdominal pressures
Vascular Access
“Location, location, location!”
Subclavian Vein
Pros:
 Shorter catheter/better flow
 Less recirculation
Cons:
 Potential for kinking
 Difficult hemostasis
 Potential for venous narrowing
 Less accessible with cervical trauma
Vascular Access
“Location, location, location!”
Internal Jugular Vein
Pros:
 Shorter catheter/better flow
 Less recirculation
Cons:
 Difficult hemostasis
 Less accessible with cervical trauma
 Catheter length problematic in small infants
Number of Patients
% Survival at 60
hours 
Catheter Size*
5 6 0 (p <0.0000)
7 57 43 (p < 0.002)
8 65 55 (NS)
9 35 51 (p < 0.002)
10 46 53 (NS)
11.5 71 57 (NS)
12.5 64 60 (NS)
Insertion Site
Internal Jugular 58 60 (p < 0.05)
Subclavian 31 51 (NS)
Femoral 260 52 (NS)
Hackbarth R et al: IJAIO 30:1116-21, 2007
Vascular Access
Hackbarth R et al: IJAIO 30:1116-21, 2007
Survival favors IJ
Location (p< 0.05)
Vascular Access
Catheter proximity
 Inadvertent removal of infusions
 Circuit clotting with platelet transfusions
 Entraining calcium into the circuit
Vascular Access
Note the relationship of the line tips.
Vascular Access for Pediatric
CRRT
(Hackbarth et al, CRRT 2005)
 Children on CRRT/24 months
 Age range 2 days – 18 yrs
 Wt range 2.5-78 Kg
 Citrate anticoagulation
 Avg circuit life 3.1 days (0.3-11 days)
 Access was size dependent
 7 Fr dual lumen with clot in 50%
 Avg BFR 27 mls/min
 8 Fr dual lumen with clot in 20%
 Avg BFR 73 mls/min
 12 Fr triple lumen with no clot in any
 Avg BFR 127 mls/min
 This was used in in all children > 35 kg
Vascular Access for Pediatric
CRRT
(Hackbarth et al, CRRT 2005)
Triple vs Dual in Peds RRT
 5 year experience with Pediatric CRRT using
the “pigtail” as the CaCL replacement
 If not for citrate CRRT also serves as an
added central line for other med/TPN infusion
 What staff at bedside ever has sufficient
central access?
Vascular Access
What size catheter should we use?
 Don’t use a 5 French catheter.
 Choose the largest diameter that is safe for the child.
 Choose the smallest catheter that will achieve the
necessary flow easily.
 Choose the the minimum length to position the tip for
optimal flow.
 In the femoral position, longer catheters will minimize
recirculation
Vascular Access
Where should the catheter go?
 What sites are available?
 Are there anatomic or physiologic constraints?
 Which vessel is optimal for the catheter size?
 Is the patient coagulopathic?
 Consider patient mobility and risk of kinking.
 Is there elevated intra-abdominal pressure?
Vascular Access
Where should the catheter go?
Answer: Internal Jugular vein if possible
PATIENT SIZE CATHETER SIZE &
SOURCE
SITE OF INSERTION
NEONATE Single-lumen 5 Fr (COOK) Femoral artery or vein
Dual-Lumen 7.0 French
(COOK/MEDCOMP)
Femoral vein
3-6 KG Dual-Lumen 7.0 French
(COOK/MEDCOMP)
Internal/External-Jugular,
Subclavian or Femoral vein
Triple-Lumen 7.0 Fr
(MEDCOMP)
Internal/External-Jugular,
Subclavian or Femoral vein
6-30 KG Dual-Lumen 8.0 French
(KENDALL/ARROW)
Internal/External-Jugular,
Subclavian or Femoral vein
>15-KG Dual-Lumen 9.0 French
(MEDCOMP)
Internal/External-Jugular,
Subclavian or Femoral vein
>30 KG Dual-Lumen 10.0 French
(KENDALL, ARROW)
Internal/External-Jugular,
Subclavian or Femoral vein
>30 KG Triple-Lumen 12 French
(KENDALL/ ARROW)
Internal/External-Jugular,
Subclavian or Femoral vein

More Related Content

PPTX
Central Venous Access
PPTX
Vascular access in neonates small children dr. rasha helmy
PPTX
Vascular access in pediatrics
PPTX
INTERVENTIONAL PROCEDURE IN CHILDREN.pptx
PPT
2012 vascular access pt 1
PPTX
Vascular access in pediatric population.
PPT
14048227.ppt
Central Venous Access
Vascular access in neonates small children dr. rasha helmy
Vascular access in pediatrics
INTERVENTIONAL PROCEDURE IN CHILDREN.pptx
2012 vascular access pt 1
Vascular access in pediatric population.
14048227.ppt

Similar to 6008061.ppt (20)

PPTX
Temporary vascular access for hemodialysis
PPTX
CENTRAL VENOUS ACCESS / PROCEDURES IN PICU
PPTX
Pediatrics vascular access and their types.pptx
PDF
Central line insertion
PPTX
Cardiac cath principles in pediatrics
PPTX
VASCULAR INTERVENTIONAL STUDIES by joginder.pptx
PPTX
2020 parm 2223 u5 introduction to central venous access
PPTX
2020 parm 2223 u5 introduction to central venous access and Infusion Pumps
PPTX
SHARE WITH SLIDE SHAREJVBKJLJNLNLNLLK.pptx
PPTX
SLIDE SHARE.pptxFFJHBKBKJJBJBJBKJBKJBKJBKJB
PPTX
SHARE WITH SLIDE SHARE HVVJGHIUHOHOIHOHOHO
PPTX
SLIDE SHARE.pptx MM
PPTX
567961 (1).pptx
PPTX
Interventional Radiology in General Surgery.pptx
PPT
2013 Pediatric Subspecialty Boot Camp_Central venous access
PPTX
Central venous access devices all you need to know
PPTX
"Central Venous Access: Techniques, Complications, and Best Practices" - by D...
PPTX
1. peripheral and midline iv lines
PDF
Vascular Access Part 1: Reducing risk and increasing catheter longevity
PPTX
IR basics.pptx Interventional Radiology Guide wires, catheters, needles
Temporary vascular access for hemodialysis
CENTRAL VENOUS ACCESS / PROCEDURES IN PICU
Pediatrics vascular access and their types.pptx
Central line insertion
Cardiac cath principles in pediatrics
VASCULAR INTERVENTIONAL STUDIES by joginder.pptx
2020 parm 2223 u5 introduction to central venous access
2020 parm 2223 u5 introduction to central venous access and Infusion Pumps
SHARE WITH SLIDE SHAREJVBKJLJNLNLNLLK.pptx
SLIDE SHARE.pptxFFJHBKBKJJBJBJBKJBKJBKJBKJB
SHARE WITH SLIDE SHARE HVVJGHIUHOHOIHOHOHO
SLIDE SHARE.pptx MM
567961 (1).pptx
Interventional Radiology in General Surgery.pptx
2013 Pediatric Subspecialty Boot Camp_Central venous access
Central venous access devices all you need to know
"Central Venous Access: Techniques, Complications, and Best Practices" - by D...
1. peripheral and midline iv lines
Vascular Access Part 1: Reducing risk and increasing catheter longevity
IR basics.pptx Interventional Radiology Guide wires, catheters, needles

More from anesthesia2023 (20)

PPT
3908843.ppt
PPT
4484085.ppt
PPTX
How To Think Like A Programmer (1).pptx
PPT
16934165.ppt
PPT
3913479.ppt
PPT
13337238.ppt
PPT
12572001.ppt
PPT
6098714.ppt
PPT
8323597.ppt
PPT
12452550.ppt
PPT
3936599.ppt
PPT
THROMBOLYTIC DRUGS.ppt
PPT
9572195.ppt
PPT
4556210.ppt
PPT
17100493.ppt
PPT
11780314.ppt
PPT
10800669.ppt
PPT
ANALYTICAL.ppt
PPTX
presenation of Anaesthesia for laparoscopic surgery.pptx
PPTX
Hemodynamic Monitoring .pptx
3908843.ppt
4484085.ppt
How To Think Like A Programmer (1).pptx
16934165.ppt
3913479.ppt
13337238.ppt
12572001.ppt
6098714.ppt
8323597.ppt
12452550.ppt
3936599.ppt
THROMBOLYTIC DRUGS.ppt
9572195.ppt
4556210.ppt
17100493.ppt
11780314.ppt
10800669.ppt
ANALYTICAL.ppt
presenation of Anaesthesia for laparoscopic surgery.pptx
Hemodynamic Monitoring .pptx

Recently uploaded (20)

PDF
OR Royalties Inc. - Q2 2025 Results, August 6, 2025
PDF
North Arrow Minerals Corporate and Kraaipan Project Update
PDF
Collective Mining | Corporate Presentation - August 2025
PDF
Probe Gold Corporate Presentation Aug 2025 Final.pdf
PDF
Update on North Arrow Minerals and the Kraaipan Gold Project, Botswanaf
PPTX
Chemistry.pptxjhghjgghgyughgyghhhvhbhghjbjb
PPTX
North Arrow Corporate Update for August 5, 2025
PDF
TIM Group - Results Presentation H1 '25.pdf
PDF
OR Royalties Inc. - Corporate Presentation, August 2025
PPTX
TTL1_LMS-Presenfdufgdfgdgduhfudftation.pptx
PDF
How to Analyze Market Trends in Precious Metal.pdf
PPTX
CCA文凭办理|加利福尼亚艺术学院毕业证海牙认证网上可查学历文凭
PDF
Deutsche EuroShop | Company Presentation | 08/25
PPTX
The Future of Philanthropy - AI & Donor Engagement
PPTX
investment-opportunities-in-rajasthan.pptx
PDF
Methanex Investor Presentation - July 2025
PDF
Cyberagent_For New Investors_EN_250808.pdf
PDF
Investor Presentation - Q2 FY 25 - 6 November 2024.pdf
DOCX
The Future of Investment Advice in a Tokenized World.docx
PDF
202507_Sansan presentation materials FY2024
OR Royalties Inc. - Q2 2025 Results, August 6, 2025
North Arrow Minerals Corporate and Kraaipan Project Update
Collective Mining | Corporate Presentation - August 2025
Probe Gold Corporate Presentation Aug 2025 Final.pdf
Update on North Arrow Minerals and the Kraaipan Gold Project, Botswanaf
Chemistry.pptxjhghjgghgyughgyghhhvhbhghjbjb
North Arrow Corporate Update for August 5, 2025
TIM Group - Results Presentation H1 '25.pdf
OR Royalties Inc. - Corporate Presentation, August 2025
TTL1_LMS-Presenfdufgdfgdgduhfudftation.pptx
How to Analyze Market Trends in Precious Metal.pdf
CCA文凭办理|加利福尼亚艺术学院毕业证海牙认证网上可查学历文凭
Deutsche EuroShop | Company Presentation | 08/25
The Future of Philanthropy - AI & Donor Engagement
investment-opportunities-in-rajasthan.pptx
Methanex Investor Presentation - July 2025
Cyberagent_For New Investors_EN_250808.pdf
Investor Presentation - Q2 FY 25 - 6 November 2024.pdf
The Future of Investment Advice in a Tokenized World.docx
202507_Sansan presentation materials FY2024

6008061.ppt

  • 1. Vascular Access for CRRT Timothy E Bunchman Professor & Director Helen DeVos Children’s Hospital Grand Rapids, MI (Thanks to Rick Hackbarth MD for his help and slides)
  • 2. Access  If you don’t have it you might as well go home.  This is the most important aspect of CRRT therapy.  Adequacy.  Filter life.  Increased blood loss.  Staff satisfaction.
  • 3. Vascular Access  Ideal Catheter Characteristics  Easy Insertion  Permits Adequate Blood Flow without Vessel Damage  Minimal Technical Flaws  High Recirculation Rate  Kinking  Shorter and Larger Catheters SIZE DOES MATTER  Lower Resistance  Improved Bloodflow
  • 4. Vascular Access for CRRT  Match catheter size to patient size and anatomical site  One dual- or triple-lumen or two single lumen uncuffed catheters  Sites  femoral  internal jugular  avoid sub-clavian vein if possible
  • 5. Pediatric CRRT Vascular Access: Performance = Blood Flow  Minimum 30 to 50 ml/min to minimize access and filter clotting  Maximum rate of 400 ml/min/1.73m2 or  10-12 ml/kg/min in neonates and infants  4-6 ml/kg/min in children  2-4 ml/kg/min in adolescents
  • 6. Vascular Access Two questions to be answered-  What size catheter to use?  Where to put it?
  • 7. Femoral vs IJ catheter performance  26 femoral  19 > 20 cm  7 < 20cm  13 IJ  Qb 250 ml/min (ultrasound dilution)  Recirculation measurement by ultrasound dilution method Little et al: AJKD 36:1135-9, 2000
  • 8. Femoral vs IJ catheter performance Type Number Qb (ml/min) Recirculation(%) 95% CI Femoral 26 237.1 13.1* 7.6 to 18.6 > 20cm 19 233.3 8.5** 2.9 to 13.7 < 20cm 7 247.5 26.3** 17.1 to 35.5 Jugular 13 226.4 0.4* -0.1 to 1.0 Little et al: AJKD 36:1135-9, 2000 * p<0.001 ** p<0.007
  • 9. Vascular Access ppCRRT Registry Access Study  13 Pediatric Institutions  376 patients  1574 circuits  Circuit survival by Catheter size, site, and modality Hackbarth R et al: IJAIO 30:1116-21, 2007
  • 10. Vascular Access Figure 2: Mean Patient Weight vs Catheter Size 0 20 40 60 80 100 5 French 7 French 8 French 9 French 10 French 11.5 French 12.5 French Catheter Size Kg Hackbarth R et al: IJAIO 30:1116-21, 2007
  • 11. Number of Patients % Survival at 60 hours  Catheter Size* 5 6 0 (p <0.0000) 7 57 43 (p < 0.002) 8 65 55 (NS) 9 35 51 (p < 0.002) 10 46 53 (NS) 11.5 71 57 (NS) 12.5 64 60 (NS) Insertion Site Internal Jugular 58 60 (p < 0.05) Subclavian 31 51 (NS) Femoral 260 52 (NS) Hackbarth R et al: IJAIO 30:1116-21, 2007
  • 12. Vascular Access Hackbarth R et al: IJAIO 30:1116-21, 2007 Shorter life span for 7 and 9 French catheters (p< 0.002) 1st 72 hrs of circuit life only
  • 13. Figure 1: Catheter Location by Size 0 10 20 30 40 50 60 70 80 90 100 5 French 7 French 8 French 9 French 10 French 11.5 French 12.5 French Catheter Size % Femoral IJ Subclavian Unknown Hackbarth R et al: IJAIO 30:1116-21, 2007
  • 14. Vascular Access “Location, location, location!” Femoral Vein Pros:  Accessible under almost any conditions  Easier to maintain hemostasis Cons:  Potential for kinking  More recirculation  Thrombosis  Problematic flow with increased abdominal pressures
  • 15. Vascular Access “Location, location, location!” Subclavian Vein Pros:  Shorter catheter/better flow  Less recirculation Cons:  Potential for kinking  Difficult hemostasis  Potential for venous narrowing  Less accessible with cervical trauma
  • 16. Vascular Access “Location, location, location!” Internal Jugular Vein Pros:  Shorter catheter/better flow  Less recirculation Cons:  Difficult hemostasis  Less accessible with cervical trauma  Catheter length problematic in small infants
  • 17. Number of Patients % Survival at 60 hours  Catheter Size* 5 6 0 (p <0.0000) 7 57 43 (p < 0.002) 8 65 55 (NS) 9 35 51 (p < 0.002) 10 46 53 (NS) 11.5 71 57 (NS) 12.5 64 60 (NS) Insertion Site Internal Jugular 58 60 (p < 0.05) Subclavian 31 51 (NS) Femoral 260 52 (NS) Hackbarth R et al: IJAIO 30:1116-21, 2007
  • 18. Vascular Access Hackbarth R et al: IJAIO 30:1116-21, 2007 Survival favors IJ Location (p< 0.05)
  • 19. Vascular Access Catheter proximity  Inadvertent removal of infusions  Circuit clotting with platelet transfusions  Entraining calcium into the circuit
  • 20. Vascular Access Note the relationship of the line tips.
  • 21. Vascular Access for Pediatric CRRT (Hackbarth et al, CRRT 2005)  Children on CRRT/24 months  Age range 2 days – 18 yrs  Wt range 2.5-78 Kg  Citrate anticoagulation  Avg circuit life 3.1 days (0.3-11 days)  Access was size dependent
  • 22.  7 Fr dual lumen with clot in 50%  Avg BFR 27 mls/min  8 Fr dual lumen with clot in 20%  Avg BFR 73 mls/min  12 Fr triple lumen with no clot in any  Avg BFR 127 mls/min  This was used in in all children > 35 kg Vascular Access for Pediatric CRRT (Hackbarth et al, CRRT 2005)
  • 23. Triple vs Dual in Peds RRT  5 year experience with Pediatric CRRT using the “pigtail” as the CaCL replacement  If not for citrate CRRT also serves as an added central line for other med/TPN infusion  What staff at bedside ever has sufficient central access?
  • 24. Vascular Access What size catheter should we use?  Don’t use a 5 French catheter.  Choose the largest diameter that is safe for the child.  Choose the smallest catheter that will achieve the necessary flow easily.  Choose the the minimum length to position the tip for optimal flow.  In the femoral position, longer catheters will minimize recirculation
  • 25. Vascular Access Where should the catheter go?  What sites are available?  Are there anatomic or physiologic constraints?  Which vessel is optimal for the catheter size?  Is the patient coagulopathic?  Consider patient mobility and risk of kinking.  Is there elevated intra-abdominal pressure?
  • 26. Vascular Access Where should the catheter go? Answer: Internal Jugular vein if possible
  • 27. PATIENT SIZE CATHETER SIZE & SOURCE SITE OF INSERTION NEONATE Single-lumen 5 Fr (COOK) Femoral artery or vein Dual-Lumen 7.0 French (COOK/MEDCOMP) Femoral vein 3-6 KG Dual-Lumen 7.0 French (COOK/MEDCOMP) Internal/External-Jugular, Subclavian or Femoral vein Triple-Lumen 7.0 Fr (MEDCOMP) Internal/External-Jugular, Subclavian or Femoral vein 6-30 KG Dual-Lumen 8.0 French (KENDALL/ARROW) Internal/External-Jugular, Subclavian or Femoral vein >15-KG Dual-Lumen 9.0 French (MEDCOMP) Internal/External-Jugular, Subclavian or Femoral vein >30 KG Dual-Lumen 10.0 French (KENDALL, ARROW) Internal/External-Jugular, Subclavian or Femoral vein >30 KG Triple-Lumen 12 French (KENDALL/ ARROW) Internal/External-Jugular, Subclavian or Femoral vein